Cargando…

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma

An emerging hallmark of cancer is reprogrammed cellular metabolism, and several cancers involve increased glucose intake and glutamine addiction. Hepatocellular carcinoma (HCC) is one of the most fatal cancers, and its molecular basis needs to be delineated to identify biomarkers for its potential t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hong-Wei, Yu, Xing-Juan, Wu, Wen-Chao, Chen, Jing, Shi, Ming, Zheng, Limin, Xu, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201247/ https://www.ncbi.nlm.nih.gov/pubmed/28036362 http://dx.doi.org/10.1371/journal.pone.0168907

Ejemplares similares

GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis
por: Ibrahiem, Afaf T, et al.
Publicado: (2022)

BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1
por: Wang, Peng, et al.
Publicado: (2023)

Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
por: Liu, Chao-Qun, et al.
Publicado: (2018)

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2017)

High S100A9(+) cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection
por: Liao, Jing, et al.
Publicado: (2021)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2015)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer
por: Li, Jin-Qing, et al.
Publicado: (2017)

Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation()
por: Yang, Hai-Jing, et al.
Publicado: (2016)

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
por: Xiao, Gang, et al.
Publicado: (2019)

TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
por: Yuan, Ming-Ming, et al.
Publicado: (2015)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion
por: Zhang, Congyi, et al.
Publicado: (2022)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
por: Cooper, R, et al.
Publicado: (2003)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
por: Strati, Paolo, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma
por: Zhu, Zheng-yi, et al.
Publicado: (2022)

Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2023)

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study
por: Yan, Wen-Tao, et al.
Publicado: (2021)

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2021)

SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
por: Chen, Shaosen, et al.
Publicado: (2017)

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
por: Ayala, Fernanda Rocha Rojas, et al.
Publicado: (2010)

GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle
por: Aerni-Flessner, Lauren, et al.
Publicado: (2012)

SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma
por: Kim, Yun Hak, et al.
Publicado: (2017)

ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma
por: Xu, Jun Hui, et al.
Publicado: (2021)

Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patients
por: Zhao, Ying, et al.
Publicado: (2017)

Immune-associated molecular occurrence and prognosis predictor of hepatocellular carcinoma: an integrated analysis of GEO datasets
por: Liu, Guanjun, et al.
Publicado: (2021)

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015)

Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2
por: Zander, Catherine B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tklbrs2lhi1p43efuu2fde6l2o